Supplementary Fig. 5 from Anti-tumor efficacy of the novel KIT inhibitor IDRX-42 (formerly M4205) in patient- and cell line-derived xenograft models of gastrointestinal stromal tumor (GIST)

Supplementary Fig. 5. Average number of apoptotic cells per treatment group in 10 high power fields assessed on (A) hematoxylin and eosin (H&E) staining and on (B) cleaved poly-ADP-ribose-polymerase (cPARP) staining.